Atrys Health, S.A. (ATRY.MC)

EUR 3.11

(0.32%)

Revenue Summary of Atrys Health, S.A.

Atrys Health, S.A.'s latest annual revenue in 2023 was 201.56 Million EUR , up 7.79% from previous year.
Atrys Health, S.A.'s latest quarterly revenue in 2024 Q2 was 54.68 Million EUR , down -4.48% from previous quarter.
Atrys Health, S.A. reported a annual revenue of 186.99 Million EUR in annual revenue 2022, up 54.52% from previous year.
Atrys Health, S.A. reported a annual revenue of 121.01 Million EUR in annual revenue 2021, up 285.44% from previous year.
Atrys Health, S.A. reported a quarterly revenue of 54.68 Million EUR for 2024 Q2, down -4.48% from previous quarter.
Atrys Health, S.A. reported a quarterly revenue of 60.15 Million EUR for 2023 Q1, down -37.46% from previous quarter.

Annual Revenue Chart of Atrys Health, S.A. (2023 - 2012)

Historical Annual Revenue of Atrys Health, S.A. (2023 - 2012)

Year	Revenue	Revenue Growth
2023	201.56 Million EUR	7.79%
2022	186.99 Million EUR	54.52%
2021	121.01 Million EUR	285.44%
2020	31.39 Million EUR	111.61%
2019	14.83 Million EUR	103.41%
2018	7.29 Million EUR	20.86%
2017	6.03 Million EUR	32.33%
2016	4.56 Million EUR	59.14%
2015	2.86 Million EUR	163.02%
2014	1.08 Million EUR	6.94%
2013	1.01 Million EUR	-5.59%
2012	1.07 Million EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	57.24 Million EUR	-31.3%
2024 Q2	54.68 Million EUR	-4.48%
2023 Q1	60.15 Million EUR	-37.46%
2023 Q4	83.33 Million EUR	94.28%
2023 FY	201.56 Million EUR	7.79%
2023 Q3	42.89 Million EUR	-63.72%
2023 Q2	118.23 Million EUR	96.54%
2022 Q2	90.8 Million EUR	100.68%
2022 FY	186.99 Million EUR	54.52%
2022 Q3	49.71 Million EUR	-45.25%
2022 Q1	45.24 Million EUR	-42.95%
2022 Q4	96.18 Million EUR	93.46%
2021 Q4	79.3 Million EUR	96.35%
2021 Q2	41.7 Million EUR	93.67%
2021 Q3	40.39 Million EUR	-3.15%
2021 FY	121.01 Million EUR	285.44%
2021 Q1	21.53 Million EUR	76.37%
2020 FY	31.39 Million EUR	111.61%
2020 Q2	4.69 Million EUR	-0.0%
2020 Q1	4.69 Million EUR	-46.4%
2020 Q3	12.2 Million EUR	160.09%
2020 Q4	12.2 Million EUR	0.0%
2019 Q4	8.75 Million EUR	80.66%
2019 Q2	6.07 Million EUR	74.6%
2019 Q3	4.84 Million EUR	-20.23%
2019 Q1	3.48 Million EUR	-15.33%
2019 FY	14.83 Million EUR	103.41%
2018 Q1	2.18 Million EUR	-1.21%
2018 FY	7.29 Million EUR	20.86%
2018 Q4	4.11 Million EUR	66.46%
2018 Q3	2.46 Million EUR	-22.41%
2018 Q2	3.18 Million EUR	45.75%
2017 Q4	2.21 Million EUR	0.0%
2017 FY	6.03 Million EUR	32.33%
2017 Q2	1.8 Million EUR	0.0%
2017 Q1	1.8 Million EUR	14.92%
2017 Q3	2.21 Million EUR	22.55%
2016 Q1	1.41 Million EUR	0.0%
2016 Q2	1.41 Million EUR	-0.0%
2016 FY	4.56 Million EUR	59.14%
2016 Q4	1.56 Million EUR	0.0%
2016 Q3	1.56 Million EUR	11.2%
2015 FY	2.86 Million EUR	163.02%
2014 FY	1.08 Million EUR	6.94%
2013 FY	1.01 Million EUR	-5.59%
2012 FY	1.07 Million EUR	0.0%

Peer Revenue Comparison of Atrys Health, S.A.

Name	Revenue	Revenue Difference
Biotechnologies Assets SA	3.9 Million EUR	-5057.287%
Pharma Mar, S.A.	158.15 Million EUR	-27.452%
Laboratorios Farmaceuticos Rovi, S.A.	829.5 Million EUR	75.7%